More importantly, the elevated UBE2L3 expression was closely associated with poorer survival of NSCLC as determined by the Kaplan-Meier and log-rank tests for survival analysis (Figure 1E). The gene discussed is UBE2L3; the disease is non-small cell lung carcinoma.